Conference Coverage (NCVDG)
New Antibody Protects Against HIV Even After Exposure
Published in AIDS Weekly, June 2nd, 1997
The MAb, dubbed B4, was developed by United Biomedical Inc. (UBI), Hauppage, New York.
If B4 works in humans, it could be used as a "morning-after" drug to prevent HIV infection after exposure to the virus. A vaccine that stimulated B4-like antibodies could also be developed.
"B4, in humanized form, is a promising candidate for use in post-exposure prophylaxis," said Carl V. Hanson of the California Department of Health Services, Berkeley, California. "A new approach to HIV vaccine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1997-06-02)
More Articles from AIDS Weekly
- Conference Coverage (NCVDG)
Goat Virus May Protect Against HIV - Conference Coverage (NCVDG)
HIV Clade Variability May Not Affect Vaccines - Conference Coverage (NCVDG)
HIV Evokes Mucosal Immunity in Semen, Cervix - Conference Coverage (NCVDG)
Researchers Closing In on Elusive CAF - Conference Coverage (NCVDG)
Uninfected Sex Partners: Saved by Mucosal Immunity to HIV? - AIDS Impact
AIDS Expected to Impact South Africa's Population Significantly Over the Next 28 Years - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
